| Literature DB >> 35989963 |
Ozun Bayındır1, Gülseren Akyüz1, Nimet Sekban1.
Abstract
Objectives: This study aimed to investigate the effectiveness of adding robot-assisted hand therapy (HandTutor) to conventional rehabilitation program compared to a conventional rehabilitation program alone in stroke survivors. Patients and methods: Between March 2012 and December 2012, a total of 33 stroke patients (21 males, 12 females; median age: 56 years; range, 38 to 73 years) were included in this prospective, randomized-controlled study. The patients were randomly divided into two groups as experimental (n=16) and control (n=17). Both groups received conventional rehabilitation for 3 h/day, for two days/week, totally for five weeks, while the experimental group received additional 1-hour robot-assisted hand therapy during each session. Outcome measures were the Fugl-Meyer Assessment, Box and Block Test, Nine-Hole Peg Test, Jebsen-Taylor Hand Function Test, grip strength, and pinch strength. All patients were assessed at baseline, at the end of the treatment, and three months after the treatment.Entities:
Keywords: Functional activities; muscle strength; robot-assisted therapy; stroke
Year: 2022 PMID: 35989963 PMCID: PMC9366479 DOI: 10.5606/tftrd.2022.8705
Source DB: PubMed Journal: Turk J Phys Med Rehabil ISSN: 2587-1250
Demographic and stroke-related characteristics between groups
| Control (n=17) | Experimental (n=16) | ||||||||
| n | % | Median | IQR 25th-75th | n | % | Median | IQR 25th-75th | ||
| Age (year) | 58 | 51-64 | 55.5 | 53.5-66.5 | 0.631* | ||||
| Stroke duration (month) | 4 | 4-15 | 9 | 3-35 | 0.736* | ||||
| Sex | 0.818# | ||||||||
| Female | 7 | 41.2 | 5 | 31.2 | |||||
| Male | 10 | 58.8 | 11 | 68.8 | |||||
| Type of stroke | 1.000# | ||||||||
| Ischemic | 10 | 58.8 | 10 | 62.5 | |||||
| Hemorrhagic | 7 | 41.2 | 6 | 37.5 | |||||
| Involved side | 1.000# | ||||||||
| Right | 8 | 47.1 | 7 | 43.8 | |||||
| Left | 9 | 52.9 | 9 | 56.2 | |||||
| IQR: Interquartile range; * Mann-Whitney U test; # Chi-square test, p<0.05. | |||||||||
Comparison of functional and strength related assessments between groups
| Control (n=17) | Experimental (n=16) | ||||
| Median | IQR 25th-75th | Median IQR 25th-75th | |||
| Fugl-Meyer Assessment | |||||
| Baseline | 51 | 49-54 | 51 | 50-53 | 0,958 |
| At the end of treatment | 57 | 55-58 | 56,5 | 55,5-59 | 0,606 |
| Follow-up | 61 | 57-62 | 60 | 58-62 | 0,845 |
| p# | <0.001 | <0.001 | |||
| <0.001† | <0.001† | ||||
| <0.0011‡ | <0.0011‡ | ||||
| 0.001¶ | 0.001¶ | ||||
| Box and Block Test | |||||
| Baseline | 28 | 21-31 | 24,5 | 16-30,5 | 0,606 |
| At the end of treatment | 36 | 27-42 | 41 | 22,5-49 | 0,488 |
| Follow-up | 38 | 34-49 | 48 | 31.5-55.5 | 0,191 |
| p# | <0.001 | <0.001 | |||
| <0.001† | <0.001† | ||||
| <0.0011‡ | <0.0011‡ | ||||
| 0.015¶ | 0.001¶ | ||||
| Nine Hole Peg Test | |||||
| Baseline | 60 | 45.3-136.3 | 143,2 | 53,5-195 | 0,309 |
| At the end of treatment | 34,5 | 28.8-59.9 | 48,7 | 30,4-95 | 0,488 |
| Follow-up | 32,5 | 27.3-70.6 | 40,4 | 25.3-90.0 | 0,683 |
| p# | <0.001 | <0.001 | |||
| <0.001† | <0.001† | ||||
| <0.0011‡ | <0.0011‡ | ||||
| 0.653¶ | 0.001¶ | ||||
| Jebsen Taylor Hand Function Test | |||||
| Baseline | 105,2 | 69-134.8) | 119,3 | 91.1-213.5 | 0,326 |
| At the end of treatment | 56,5 | 46.9-106.2 | 62,6 | 44.9-109.7 | 0,845 |
| Follow-up | 56,8 | 44.9-91.2 | 49,1 | 39.1-86.2 | 0,465 |
| p# | <0.001 | <0.001 | |||
| <0.001† | <0.001† | ||||
| <0.0011‡ | <0.0011‡ | ||||
| 0.619¶ | p3<0.001¶ | ||||
| Pinch strength | |||||
| Baseline | 4 | 3-5 | 4 | 2-6 | 0,817 |
| At the end of treatment | 5 | 4-6 | 5,5 | 3,5-8 | 0,276 |
| Follow-up | 5 | 4-7 | 6,5 | 5-11 | 0,157 |
| p# | <0.001 | <0.001 | |||
| 0.034† | 0.004† | ||||
| 0.0021‡ | <0.0011‡ | ||||
| 0.016¶ | 0.005¶ | ||||
| Grip strength | |||||
| Baseline | 10 | 6-15 | 12,5 | 8-20 | 0,465 |
| At the end of treatment | 12 | 10-20 | 15 | 12-25 | 0,276 |
| Follow-up | 12 | 10-20 | 20 | 12-30 | 0,136 |
| p# | <0.001 | <0.001 | |||
| 0.001† | 0.003† | ||||
| 0.0011‡ | 0.0011‡ | ||||
| 0.551¶ | 0.015¶ | ||||
| IQR: Interquartile range; * Mann-Whitney U test; # Friedman test; † Baseline vs. at the end of the treatment; ‡ Baseline vs. follow-up; ¶ At the end of the treatment vs. follow up, p<0.05. | |||||
Comparison of the changes between groups
| Control (n=17) | Experimental (n=16) | ||||
| Median | IQR 25th-75th | Median | IQR 25th-75th | ||
| ΔFugl-Meyer Assessment | |||||
| Baseline-At the end of treatment | 4 | 3-6 | 5 | 4-7 | 0.101 |
| Baseline-Follow-up | 8 | 6-9 | 8 | 6-9 | 0.606 |
| ΔBox and Block Test | |||||
| Baseline-At the end of treatment | 8 | 4-12 | 12.5 | 8-21 | 0.045 |
| Baseline-Follow-up | 10 | 8-16 | 23.5 | 15.5-31 | 0.010 |
| ΔNine Hole Peg Test | |||||
| Baseline-At the end of treatment | -31.0 | -60.1 - -16.9 | -78.9 | -113.7 - -20.5 | 0.074 |
| Baseline-Follow-up | -30.0 | -43.4 - -13.2 | -90.7 | -117.1 - -24.5 | 0.015 |
| ΔJebsen Taylor Hand Function Test | |||||
| Baseline-At the end of treatment | -28.9 | -59.2 - -19.5 | -55.8 | -87.8 - -33.5 | 0.063 |
| Baseline-Follow-up | -22.5 | -59.6 - -19.2 | -65.5 | -121.4 - -45.0 | 0.010 |
| ΔPinch strength | |||||
| Baseline-At the end of treatment | 0 | 0-1 | 1.5 | 0.5-2.5 | 0.049 |
| Baseline-Follow-up | 1 | 0-2 | 2.5 | 2-4.5 | <0.001 |
| ΔGrip strength | |||||
| Baseline-At the end of treatment | 4 | 2-4 | 5 | 0-6 | 0.382 |
| Baseline-Follow-up | 4 | 2-5 | 6.5 | 3.5-12.5 | 0.012 |
| IQR: Interquartile range; Δ: Delta; * Mann-Whitney U test; p<0.05. | |||||